¡Iniciando! Mobile App for Latino Youth with ASD

This study is testing a mobile app called ¡Iniciando! to help Latino young adults (ages 18-25) with Autism Spectrum Disorder (ASD) and their families navigate the transition to adulthood. The researchers want to see how easy the app is to use, if people are happy with it, and how much they use it. They also want to understand if the app can help improve mental health, quality of life, and daily living skills for these young adults and their parents. You may be able to join if you are a Latino young adult with an ASD diagnosis and meet specific criteria. The study is currently unclear about its recruitment status, but plans to enroll 30 participants. Success in this study means understanding how well the app works and how feasible it is to use.

Study design
This is an interventional study planning to enroll 30 participants. It is not specified if it is randomized or blinded.
What's involved
Participants will attend 12 weekly, 1-hour virtual group sessions (separate for young adults and parents) and weekly, 30-minute individual virtual coaching sessions for young adults. Participants will also engage with the ¡Iniciando! app.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoints are measured at the end of the study, about 3 months after baseline.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07170163

Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families

Not Yet Recruiting
NAAges 18–25InterventionalTreatment
The University of Texas Health Science Center, Houston
~30 participants
Updated 2026-07-10 on ClinicalTrials.gov
What's tested:¡Iniciando! mHealth App

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of participants recruited
Measured over end of study (about 3 months after baseline)
+16 more outcomes measured
Autism Spectrum Disorder (ASD)

NCT07170163

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • The University of Texas Health Science Center at Houston

    Houston, Texasstudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Antonio Pagán, PhD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center, Houston

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Latino young adults with ASD ASD with a score of 15 or greater on the Social Communication Questionnaire-Lifetime (SCQ-L)
meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), criteria for ASD based on a DSM-5-TR ASD symptom checklist
previous diagnosis of ASD from a licensed mental health or medical professional(f they have not been diagnosed by a licensed mental health or medical professional, a complete a diagnostic evaluation will be conducted, using semi-structured interviews, questionnaires, the autism diagnostic interview-revised (ADI-R), and the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) to confirm ASD diagnosis)
above the "moderate" cut off for symptoms of anxiety or depression( Depression and anxiety symptoms will be assessed via the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder-7 (GAD-7)
Spanish-speaking parents

Exclusion

low intelligence quotient (IQ) score (Verbal IQ \< 70) on the verbal IQ on Kaufman Brief Intelligence Test Second Edition (KBIT-2)
psychotic as determined by the Structured clinical interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM5): Research Version (SCID-5-RV), or are actively suicidal with an active plan.
substance abuse
  • Number of participants recruitedend of study (about 3 months after baseline)
  • Source of participantsend of study (about 3 months after baseline)

    Participants maybe recruited from the following : UTHealth Houston Community Health Workers Social Media advertisements Private clinics

  • Time taken for recruitment of participantsend of study (about 3 months after baseline)
  • Number of participants that completed the studyend of study (about 3 months after baseline)
  • Usability as measured by the User Version of the Mobile Application Rating Scale (uMARS)end of study (about 3 months after baseline)

    This is a 20 item questionnaire and each item is rated on a 5-point Likert scale, scores range from 1(inadequate) to 5(excellent) with higher scores indicating better usability.

  • Usability as Measured by the System Usability Scale (SUS)end of study (about 3 months after baseline)

    The System Usability Scale (SUS) is a validated 10-item questionnaire . Each item is rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Scores are converted to a total SUS score ranging from 0 to 100, with higher scores indicating better usability. A score above 68 is generally considered above average usability.

  • Differences in outcome expectancy as assessed by the treatment credibility scalesend of study (about 3 months after baseline)

    this is a 6 item questionnaire and each is scored from 1-9, maximum score would be 54, higher score indicating better outcome

  • Treatment Adherence as assessed by the number of completed sessionsend of study (about 3 months after baseline)
  • Treatment Adherence as assessed by the homework completion rateend of study (about 3 months after baseline)
  • Treatment Adherence as assessed by the number of participants that drop outend of study (about 3 months after baseline)
  • Treatment Adherence as assessed by the time spent on homeworkend of study (about 3 months after baseline)
  • Time-used on the mHealth append of study (about 3 months after baseline)
  • Percentage of modules completed on the mHealth append of study (about 3 months after baseline)
  • Frequencies of goal setting on the mHealth append of study (about 3 months after baseline)
  • Acceptability of Intervention as assessed by the Acceptability of Intervention Measure (AIMend of study (about 3 months after baseline)

    This is a 4 item questionnaire and each is scored form 1( completely disagree) to 5 (completely agree) for a maximum score of 20, higher score indicating better outcome

  • Intervention Appropriateness as assessed by the Intervention Appropriateness Measure (IAM)end of study (about 3 months after baseline)

    This is a 4 item questionnaire and each is scored form 1( completely disagree) to 5 (completely agree) for a maximum score of 20, higher score indicating better outcome

  • Feasibility of Intervention as assessed by the Feasibility of Intervention Measure (FIM)end of study (about 3 months after baseline)

    This is a 4 item questionnaire and each is scored form 1( completely disagree) to 5 (completely agree) for a maximum score of 20, higher score indicating better outcome